Dyne Therapeutics Inc. (DYN) NASDAQ

$25.47 (0.38) (-1.47%)

Market Cap: $2.23B

As of 04/15/24 03:59 PM EDT. Market closed.

(DYN)

Dyne Therapeutics Inc. (DYN)
NASDAQ

$25.47
(0.38) (-1.47%)

Market Cap: $2.23B

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its ... read more

dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its force platform that delivers disease-modifying therapies. the company was founded in 2017 and is based in waltham, massachusetts. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joshua T. Brumm
Full Time Employees
135
CEO Compensation (Base)
$950,000
CEO Compensation (Total)
$6.94M
URL
Address
1560 Trapelo Road, MA, Waltham, 02451.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joshua T. Brumm
Full Time Employees
135
CEO Compensation (Base)
$950,000
CEO Compensation (Total)
$6.94M
Address
1560 Trapelo Road, MA, Waltham, 02451.
PRICE CHART FOR DYNE THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$26.01
Previous Close
$25.85
Days Range
$25.54 - $27.52
52 week range
$6.40 - $30.27
Volume
662,807
Avg. Volume (30 days)
1,102,376
Market Cap
$2.23B
Dividend Yield
-
P/E
-
Shares Outstanding
86,177,719
Open
$26.01
Previous Close
$25.85
Days Range
$25.54 - $27.52
52 week range
$6.40 - $30.27
Volume
662,807
Avg. Volume (30 days)
1,102,376
Market Cap
$2.23B
Dividend Yield
-
P/E
-
Shares Outstanding
86,177,719
FINANCIAL STATEMENTS FOR DYNE THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR DYNE THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
HIGH SUSANNA GATTIChief Operating OfficerMar 11, 2024 Sale$25.702,29258,904156,800Mar 13, 2024, 06:04 AM
HIGH SUSANNA GATTIChief Operating OfficerMar 08, 2024 Sale$26.6727,199725,344159,383Mar 13, 2024, 06:04 AM
McNeill JonathanChief Business OfficerMar 11, 2024 Option Exercise$5.5417,82598,750159,009Mar 13, 2024, 06:04 AM
McNeill JonathanChief Business OfficerMar 08, 2024 Option Exercise$5.5490,000498,600231,184Mar 13, 2024, 06:04 AM
McNeill JonathanChief Business OfficerMar 11, 2024 Sale$25.5019,601499,842141,184Mar 13, 2024, 06:04 AM
McNeill JonathanChief Business OfficerMar 08, 2024 Sale$26.2490,0002,361,531196,521Mar 13, 2024, 06:04 AM
Farwell WildonChief Medical OfficerMar 12, 2024 Sale$25.581,03026,347150,560Mar 12, 2024, 09:58 PM
Farwell WildonChief Medical OfficerMar 11, 2024 Sale$25.701,58540,735151,590Mar 12, 2024, 09:58 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 08, 2024 Option Exercise$5.5486,252477,836208,207Mar 12, 2024, 09:57 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 11, 2024 Sale$25.282,67267,542120,873Mar 12, 2024, 09:57 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 08, 2024 Sale$26.2286,2522,261,465177,452Mar 12, 2024, 09:57 PM
Brumm Joshua TCEO & PresidentMar 11, 2024 Option Exercise$5.5450,000277,000604,385Mar 12, 2024, 09:56 PM
Brumm Joshua TCEO & PresidentMar 08, 2024 Option Exercise$5.54363,3432,012,920917,728Mar 12, 2024, 09:56 PM
Brumm Joshua TCEO & PresidentMar 11, 2024 Sale$25.6766,3871,704,142564,313Mar 12, 2024, 09:56 PM
Brumm Joshua TCEO & PresidentMar 08, 2024 Sale$25.93363,3439,421,634715,490Mar 12, 2024, 09:56 PM
Beskrovnaya OxanaChief Scientific OfficerMar 11, 2024 Sale$25.702,08153,482152,352Mar 12, 2024, 09:42 PM
Brumm Joshua TCEO & PresidentMar 07, 2024 Sale$25.859,086234,873554,385Mar 11, 2024, 09:57 PM
Beskrovnaya OxanaChief Scientific OfficerMar 07, 2024 Sale$25.852,37361,342154,433Mar 11, 2024, 09:56 PM
HIGH SUSANNA GATTIChief Operating OfficerMar 07, 2024 Sale$25.851,59141,127186,291Mar 11, 2024, 09:56 PM
Farwell WildonChief Medical OfficerMar 07, 2024 Sale$25.869,921256,585154,732Mar 11, 2024, 09:52 PM
McNeill JonathanChief Business OfficerMar 07, 2024 Sale$25.852,43462,919141,184Mar 11, 2024, 09:50 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 07, 2024 Sale$25.852,27358,757121,955Mar 11, 2024, 09:45 PM
Rhodes Jason PDirectorMar 01, 2024 Sale$30.0546,5341,398,3471,458,691Mar 05, 2024, 05:08 PM
Atlas Venture Opportunity Fund I, L.P.10% OwnerMar 01, 2024 Sale$30.0517,099513,825847,388Mar 05, 2024, 05:07 PM
Atlas Venture Opportunity Fund I, L.P.10% OwnerMar 01, 2024 Sale$30.0529,435884,5221,458,691Mar 05, 2024, 05:07 PM
Brumm Joshua TCEO & PresidentMar 01, 2024 Option Exercise$5.5494,480523,419657,951Mar 01, 2024, 09:38 PM
Brumm Joshua TCEO & PresidentFeb 29, 2024 Option Exercise$5.545,52030,581568,991Mar 01, 2024, 09:38 PM
Brumm Joshua TCEO & PresidentFeb 29, 2024 Sale$27.505,520151,800563,471Mar 01, 2024, 09:38 PM
Brumm Joshua TCEO & PresidentMar 01, 2024 Sale$29.0494,4802,743,718638,975Mar 01, 2024, 09:38 PM
McNeill JonathanChief Business OfficerMar 01, 2024 Option Exercise$0.7324,26017,710167,878Mar 01, 2024, 09:37 PM
McNeill JonathanChief Business OfficerFeb 29, 2024 Option Exercise$0.734,2683,116147,886Mar 01, 2024, 09:37 PM
McNeill JonathanChief Business OfficerMar 01, 2024 Sale$28.6324,260694,495153,775Mar 01, 2024, 09:37 PM
McNeill JonathanChief Business OfficerFeb 29, 2024 Sale$27.504,268117,370143,618Mar 01, 2024, 09:37 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Feb 29, 2024 Option Exercise$1.033,4293,532127,657Mar 01, 2024, 09:37 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 01, 2024 Option Exercise$1.039,3119,590133,539Mar 01, 2024, 09:37 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 01, 2024 Sale$28.259,311262,999124,792Mar 01, 2024, 09:37 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Feb 29, 2024 Sale$27.503,42994,298124,228Mar 01, 2024, 09:37 PM
Rhodes Jason PDirectorFeb 26, 2024 Sale$23.72248,2195,886,6736,216,250Feb 28, 2024, 07:15 PM
Rhodes Jason PDirectorFeb 28, 2024 Sale$24.84190,9204,741,8045,700,521Feb 28, 2024, 07:15 PM
Rhodes Jason PDirectorFeb 27, 2024 Sale$24.41368,6998,998,4265,878,544Feb 28, 2024, 07:15 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 28, 2024 Sale$24.8436,246900,2281,488,486Feb 28, 2024, 07:13 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 28, 2024 Sale$24.84154,6743,841,5765,700,521Feb 28, 2024, 07:13 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 27, 2024 Sale$24.4169,9971,708,3381,514,874Feb 28, 2024, 07:13 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 27, 2024 Sale$24.41298,7027,290,0885,878,544Feb 28, 2024, 07:13 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 26, 2024 Sale$23.7247,1241,117,5771,564,932Feb 28, 2024, 07:13 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 26, 2024 Sale$23.72201,0954,769,0966,216,250Feb 28, 2024, 07:13 PM
Farwell WildonChief Medical OfficerFeb 28, 2024 Sale$25.0040710,175163,096Feb 28, 2024, 05:06 PM
Rhodes Jason PDirectorFeb 23, 2024 Sale$22.70196,9284,470,2666,352,562Feb 23, 2024, 06:59 PM
Rhodes Jason PDirectorFeb 22, 2024 Sale$22.66119,3602,704,6986,512,104Feb 23, 2024, 06:59 PM
Rhodes Jason PDirectorFeb 21, 2024 Sale$22.57184,5014,164,8176,666,628Feb 23, 2024, 06:59 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 23, 2024 Sale$22.7037,386848,6621,585,137Feb 23, 2024, 06:58 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 23, 2024 Sale$22.70159,5423,621,6046,352,562Feb 23, 2024, 06:58 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 22, 2024 Sale$22.66119,3602,704,6986,512,104Feb 23, 2024, 06:58 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 21, 2024 Sale$22.57184,5014,164,8176,666,628Feb 23, 2024, 06:58 PM
Rhodes Jason PDirectorFeb 20, 2024 Sale$22.72169,5393,852,6526,819,475Feb 20, 2024, 06:36 PM
Rhodes Jason PDirectorFeb 16, 2024 Sale$23.14162,7073,765,0406,985,504Feb 20, 2024, 06:36 PM
Rhodes Jason PDirectorFeb 15, 2024 Sale$23.89177,9064,249,6007,150,324Feb 20, 2024, 06:36 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 20, 2024 Sale$22.72169,5393,852,6526,819,475Feb 20, 2024, 06:35 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 16, 2024 Sale$23.14162,7073,765,0406,985,504Feb 20, 2024, 06:35 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 15, 2024 Sale$23.89177,9064,249,6007,150,324Feb 20, 2024, 06:35 PM
Farwell WildonChief Medical OfficerFeb 12, 2024 Sale$25.075,493137,710163,503Feb 14, 2024, 04:27 PM
Farwell WildonChief Medical OfficerJan 26, 2024 Sale$25.001002,500168,996Jan 26, 2024, 07:49 PM
McNeill JonathanChief Business OfficerJan 26, 2024 Option Exercise$0.7320,00014,600163,618Jan 26, 2024, 07:48 PM
McNeill JonathanChief Business OfficerJan 26, 2024 Sale$24.5320,000490,510143,796Jan 26, 2024, 07:48 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 26, 2024 Option Exercise$1.0313,00013,390137,228Jan 26, 2024, 07:47 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 26, 2024 Sale$24.3413,000316,420124,228Jan 26, 2024, 07:47 PM
Kersten DirkDirectorJan 09, 2024 Buy$17.501,714,28529,999,9886,416,793Jan 11, 2024, 04:31 PM
Brumm Joshua TCEO & PresidentJan 04, 2024 Option Exercise$5.16218,5361,127,092803,507Jan 04, 2024, 09:49 PM
Brumm Joshua TCEO & PresidentJan 03, 2024 Option Exercise$1.0351,18352,718636,154Jan 04, 2024, 09:49 PM
Brumm Joshua TCEO & PresidentJan 04, 2024 Sale$18.51218,5364,045,958623,272Jan 04, 2024, 09:49 PM
Brumm Joshua TCEO & PresidentJan 03, 2024 Sale$19.2851,183986,957620,772Jan 04, 2024, 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 03, 2024 Option Exercise$1.0345,32646,686221,911Jan 04, 2024, 09:48 PM
Beskrovnaya OxanaChief Scientific OfficerJan 04, 2024 Option Exercise$1.0322,67423,354199,259Jan 04, 2024, 09:48 PM
Beskrovnaya OxanaChief Scientific OfficerJan 03, 2024 Sale$18.9845,326860,313206,529Jan 04, 2024, 09:48 PM
Beskrovnaya OxanaChief Scientific OfficerJan 04, 2024 Sale$18.1342,453769,673156,806Jan 04, 2024, 09:48 PM
McNeill JonathanChief Business OfficerJan 04, 2024 Option Exercise$0.732,0091,467145,627Jan 04, 2024, 09:47 PM
McNeill JonathanChief Business OfficerJan 03, 2024 Option Exercise$0.7317,99113,133161,609Jan 04, 2024, 09:47 PM
McNeill JonathanChief Business OfficerJan 04, 2024 Sale$18.042,00936,242143,618Jan 04, 2024, 09:47 PM
McNeill JonathanChief Business OfficerJan 03, 2024 Sale$18.7417,991337,062153,918Jan 04, 2024, 09:47 PM
McNeill JonathanChief Business OfficerJan 02, 2024 Sale$13.1011,900155,890143,618Jan 04, 2024, 09:47 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 03, 2024 Option Exercise$1.0313,00013,390137,228Jan 04, 2024, 09:46 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 03, 2024 Sale$18.8113,000244,530124,228Jan 04, 2024, 09:46 PM
Scalzo Richard WilliamSee RemarksDec 14, 2023 Sale$12.022,37628,560124,228Dec 14, 2023, 04:59 PM
Scalzo Richard WilliamSee RemarksDec 11, 2023 Sale$10.721,38014,794126,604Dec 12, 2023, 05:35 PM
McNeill JonathanChief Business OfficerDec 11, 2023 Sale$10.721,24513,346155,518Dec 12, 2023, 05:34 PM
HIGH SUSANNA GATTIChief Operating OfficerDec 11, 2023 Sale$10.721,61617,324187,882Dec 12, 2023, 05:34 PM
Farwell WildonChief Medical OfficerDec 12, 2023 Sale$10.5597810,318169,096Dec 12, 2023, 05:33 PM
Farwell WildonChief Medical OfficerDec 11, 2023 Sale$10.721,68818,095170,074Dec 12, 2023, 05:33 PM
Brumm Joshua TSee RemarksDec 11, 2023 Sale$10.727,58581,311584,971Dec 12, 2023, 05:33 PM
Beskrovnaya OxanaChief Scientific OfficerDec 11, 2023 Sale$10.721,46715,726176,585Dec 12, 2023, 05:32 PM
Scalzo Richard WilliamSee RemarksDec 06, 2023 Sale$12.011,87222,483127,984Dec 06, 2023, 06:13 PM
Scalzo Richard WilliamSee RemarksDec 04, 2023 Sale$12.016818,179129,856Dec 06, 2023, 06:13 PM
HIGH SUSANNA GATTIChief Operating OfficerNov 02, 2023 Sale$7.409,93973,54994,605Nov 02, 2023, 05:16 PM
Scalzo Richard WilliamSee RemarksSep 18, 2023 Sale$9.411,29012,13940,795Sep 20, 2023, 04:49 PM
McNeill JonathanChief Business OfficerSep 18, 2023 Sale$9.411,26111,86660,605Sep 20, 2023, 04:49 PM
HIGH SUSANNA GATTIChief Operating OfficerSep 18, 2023 Sale$9.412,67225,144104,544Sep 20, 2023, 04:48 PM
Brumm Joshua TSee RemarksSep 18, 2023 Sale$9.4112,032113,221233,679Sep 20, 2023, 04:47 PM
Beskrovnaya OxanaChief Scientific OfficerSep 18, 2023 Sale$9.411,43613,51384,334Sep 20, 2023, 04:47 PM
Farwell WildonChief Medical OfficerSep 12, 2023 Sale$10.411,70717,77089,250Sep 13, 2023, 07:56 PM
Scalzo Richard WilliamSee RemarksSep 12, 2023 Sale$10.411,39714,54342,085Sep 13, 2023, 07:53 PM
McNeill JonathanChief Business OfficerSep 12, 2023 Sale$10.411,26613,17961,866Sep 13, 2023, 07:53 PM
HIGH SUSANNA GATTIChief Operating OfficerSep 12, 2023 Sale$10.411,63517,020107,216Sep 13, 2023, 07:51 PM
Brumm Joshua TSee RemarksSep 12, 2023 Sale$10.417,67279,866245,711Sep 13, 2023, 07:50 PM
Beskrovnaya OxanaChief Scientific OfficerSep 12, 2023 Sale$10.411,48415,44885,770Sep 13, 2023, 07:50 PM
Scalzo Richard WilliamSee RemarksJun 13, 2023 Option Exercise$1.0340,00041,20093,482Jun 15, 2023, 05:46 PM
Scalzo Richard WilliamSee RemarksJun 13, 2023 Sale$12.8741,390532,87853,482Jun 15, 2023, 05:46 PM
Scalzo Richard WilliamSee RemarksJun 15, 2023 Sale$12.0310,000120,30043,482Jun 15, 2023, 05:46 PM
McNeill JonathanSee RemarksJun 13, 2023 Sale$12.431,25915,64963,132Jun 14, 2023, 06:40 PM
McNeill JonathanSee RemarksJun 12, 2023 Sale$13.001,00013,00064,391Jun 14, 2023, 06:40 PM
HIGH SUSANNA GATTIChief Operating OfficerJun 13, 2023 Sale$12.431,62520,199108,851Jun 14, 2023, 06:40 PM
Farwell WildonChief Medical OfficerJun 13, 2023 Sale$12.431,69821,10690,957Jun 14, 2023, 06:40 PM
Beskrovnaya OxanaChief Scientific OfficerJun 13, 2023 Sale$12.431,47518,33487,254Jun 14, 2023, 06:39 PM
Brumm Joshua TSee RemarksJun 08, 2023 Option Exercise$1.0330,08830,991330,771Jun 12, 2023, 09:22 PM
Brumm Joshua TSee RemarksJun 12, 2023 Option Exercise$1.03171,360176,501441,131Jun 12, 2023, 09:22 PM
Brumm Joshua TSee RemarksJun 09, 2023 Option Exercise$1.0376,58278,879346,353Jun 12, 2023, 09:22 PM
Brumm Joshua TSee RemarksJun 12, 2023 Sale$12.61187,7482,367,502253,383Jun 12, 2023, 09:22 PM
Brumm Joshua TSee RemarksJun 09, 2023 Sale$13.3476,5821,021,604269,771Jun 12, 2023, 09:22 PM
Brumm Joshua TSee RemarksJun 08, 2023 Sale$13.2261,000806,690283,960Jun 12, 2023, 09:22 PM
Scalzo Richard WilliamSee RemarksMar 14, 2023 Sale$13.331,31117,47654,872Mar 15, 2023, 05:51 PM
McNeill JonathanSee RemarksMar 14, 2023 Sale$13.331,20916,11665,391Mar 15, 2023, 05:50 PM
McNeill JonathanSee RemarksMar 13, 2023 Sale$13.001,00013,00066,600Mar 15, 2023, 05:50 PM
HIGH SUSANNA GATTIChief Operating OfficerMar 14, 2023 Sale$13.331,55920,781110,476Mar 15, 2023, 05:50 PM
Farwell WildonChief Medical OfficerMar 14, 2023 Sale$13.337,44199,18992,655Mar 15, 2023, 05:49 PM
Brumm Joshua TSee RemarksMar 14, 2023 Sale$13.337,31897,549322,483Mar 15, 2023, 05:49 PM
Beskrovnaya OxanaChief Scientific OfficerMar 14, 2023 Sale$13.331,41618,87588,729Mar 15, 2023, 05:48 PM
McNeill JonathanSee RemarksJan 18, 2023 Option Exercise$0.7310,0007,30077,600Jan 23, 2023, 08:27 AM
McNeill JonathanSee RemarksJan 18, 2023 Sale$14.0310,000140,30067,600Jan 23, 2023, 08:27 AM
McNeill JonathanSee RemarksJan 09, 2023 Sale$11.5730,150348,83567,600Jan 11, 2023, 04:56 PM
Rhodes Jason PDirectorDec 12, 2022 Buy$10.70934,58110,000,017934,581Dec 14, 2022, 04:56 PM
Atlas Venture Opportunity Fund II, L.P.10% OwnerDec 12, 2022 Buy$10.70934,58110,000,017934,581Dec 14, 2022, 04:55 PM
Scalzo Richard WilliamSee RemarksDec 12, 2022 Sale$10.873123,39156,183Dec 13, 2022, 05:06 PM
McNeill JonathanSee RemarksDec 12, 2022 Sale$10.874725,13197,750Dec 13, 2022, 05:05 PM
HIGH SUSANNA GATTIChief Operating OfficerDec 12, 2022 Sale$10.877518,163112,035Dec 13, 2022, 05:05 PM
Farwell WildonChief Medical OfficerDec 12, 2022 Sale$10.876286,826100,096Dec 13, 2022, 05:04 PM
Brumm Joshua TSee RemarksDec 12, 2022 Sale$10.873,32236,110329,801Dec 13, 2022, 05:04 PM
Beskrovnaya OxanaChief Scientific OfficerDec 12, 2022 Sale$10.876807,39290,145Dec 13, 2022, 05:03 PM
Brumm Joshua TSee RemarksOct 10, 2022 Option Exercise$1.03195,800201,674400,423Oct 11, 2022, 09:00 AM
Brumm Joshua TSee RemarksOct 07, 2022 Option Exercise$1.0314,20014,626218,823Oct 11, 2022, 09:00 AM
Brumm Joshua TSee RemarksOct 10, 2022 Sale$12.46195,8002,439,668204,623Oct 11, 2022, 09:00 AM
Brumm Joshua TSee RemarksOct 07, 2022 Sale$13.3714,200189,854204,623Oct 11, 2022, 09:00 AM
Scalzo Richard WilliamSee RemarksSep 20, 2022 Option Exercise$13.7084011,50825,495Sep 21, 2022, 04:09 PM
McNeill JonathanSee RemarksSep 20, 2022 Option Exercise$13.701,24617,07058,222Sep 21, 2022, 04:08 PM
HIGH SUSANNA GATTIChief Operating OfficerSep 20, 2022 Option Exercise$13.702,62936,01768,786Sep 21, 2022, 04:08 PM
Brumm Joshua TSee RemarksSep 20, 2022 Option Exercise$13.7011,836162,153204,623Sep 21, 2022, 04:07 PM
Beskrovnaya OxanaChief Scientific OfficerSep 20, 2022 Option Exercise$13.701,41319,35850,825Sep 21, 2022, 04:07 PM
Scalzo Richard WilliamSee RemarksSep 15, 2022 Option Exercise$14.053264,58026,335Sep 15, 2022, 05:30 PM
Farwell WildonChief Medical OfficerSep 15, 2022 Option Exercise$14.056589,24564,724Sep 15, 2022, 05:28 PM
McNeill JonathanSee RemarksSep 15, 2022 Option Exercise$14.054946,94159,468Sep 15, 2022, 05:27 PM
HIGH SUSANNA GATTIChief Operating OfficerSep 15, 2022 Option Exercise$14.0578611,04371,415Sep 15, 2022, 05:26 PM
Brumm Joshua TSee RemarksSep 15, 2022 Option Exercise$14.053,48048,894216,459Sep 15, 2022, 05:25 PM
Beskrovnaya OxanaChief Scientific OfficerSep 15, 2022 Option Exercise$14.0571210,00452,238Sep 15, 2022, 05:24 PM
Brumm Joshua TSee RemarksJul 06, 2022 Option Exercise$8.2410,96390,335219,939Jul 06, 2022, 06:18 PM
Scalzo Richard WilliamSee RemarksJun 14, 2022 Option Exercise$4.953331,64826,661Jun 15, 2022, 08:05 PM
McNeill JonathanSee RemarksJun 14, 2022 Option Exercise$4.955042,49559,962Jun 15, 2022, 08:04 PM
HIGH SUSANNA GATTIChief Operating OfficerJun 14, 2022 Option Exercise$4.958023,97072,201Jun 15, 2022, 08:03 PM
Farwell WildonChief Medical OfficerJun 14, 2022 Option Exercise$4.956683,30765,382Jun 15, 2022, 08:03 PM
Brumm Joshua TSee RemarksJun 14, 2022 Option Exercise$4.953,54017,523206,784Jun 15, 2022, 08:02 PM
Beskrovnaya OxanaChief Scientific OfficerJun 14, 2022 Option Exercise$4.957263,59452,950Jun 15, 2022, 08:02 PM
Scalzo Richard WilliamSee RemarksMar 11, 2022 Sale$8.733082,68926,994Mar 14, 2022, 05:09 PM
McNeill JonathanSee RemarksMar 11, 2022 Sale$8.734814,19960,466Mar 14, 2022, 05:09 PM
HIGH SUSANNA GATTIChief Operating OfficerMar 11, 2022 Sale$8.737656,67873,003Mar 14, 2022, 05:08 PM
Farwell WildonChief Medical OfficerMar 11, 2022 Sale$8.736405,58766,050Mar 14, 2022, 05:08 PM
Brumm Joshua TSee RemarksMar 11, 2022 Sale$8.733,38429,542210,324Mar 14, 2022, 05:07 PM
Beskrovnaya OxanaChief Scientific OfficerMar 11, 2022 Sale$8.736936,05053,676Mar 14, 2022, 05:06 PM
Farwell WildonChief Medical OfficerMar 02, 2022 Sale$8.565,61748,08266,690Mar 03, 2022, 07:22 PM
HIGH SUSANNA GATTIChief Operating OfficerSep 23, 2021 Sale$17.222,45142,20633,453Sep 24, 2021, 10:50 AM
Scalzo Richard WilliamSee RemarksSep 21, 2021 Sale$16.114927,92610,606Sep 22, 2021, 08:03 PM
Scalzo Richard WilliamSee RemarksSep 20, 2021 Sale$15.613675,72911,098Sep 22, 2021, 08:03 PM
McNeill JonathanSee RemarksSep 21, 2021 Sale$16.1172911,74435,636Sep 22, 2021, 08:02 PM
McNeill JonathanSee RemarksSep 20, 2021 Sale$15.615458,50736,365Sep 22, 2021, 08:02 PM
Brumm Joshua TSee RemarksSep 21, 2021 Sale$16.114,58473,84899,018Sep 22, 2021, 08:02 PM
Brumm Joshua TSee RemarksSep 20, 2021 Sale$15.613,42553,464103,602Sep 22, 2021, 08:02 PM
Beskrovnaya OxanaChief Scientific OfficerSep 21, 2021 Sale$16.1182713,32317,845Sep 22, 2021, 08:01 PM
Beskrovnaya OxanaChief Scientific OfficerSep 20, 2021 Sale$15.616179,63118,672Sep 22, 2021, 08:01 PM
VV Manager II, LLC10% OwnerSep 21, 2020 Buy$19.00792,99515,066,9052,880,125Sep 23, 2020, 07:11 PM
VV Manager II, LLC10% OwnerSep 21, 2020 Buy$19.0022,005418,09579,921Sep 23, 2020, 07:11 PM
Logos Global Management LP10% OwnerSep 21, 2020 Buy$19.00700,00013,300,0001,504,392Sep 23, 2020, 07:09 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerSep 21, 2020 Buy$19.00660,00012,540,0002,805,045Sep 23, 2020, 06:55 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
HIGH SUSANNA GATTIChief Operating Officer03/11/202458,904
HIGH SUSANNA GATTIChief Operating Officer03/08/2024725,344
McNeill JonathanChief Business Officer03/11/202498,750
McNeill JonathanChief Business Officer03/08/2024498,600
McNeill JonathanChief Business Officer03/11/2024499,842
McNeill JonathanChief Business Officer03/08/20242,361,531
Farwell WildonChief Medical Officer03/12/202426,347
Farwell WildonChief Medical Officer03/11/202440,735
Scalzo Richard WilliamSVP, Head of Finance & Admin.03/08/2024477,836
Scalzo Richard WilliamSVP, Head of Finance & Admin.03/11/202467,542
Scalzo Richard WilliamSVP, Head of Finance & Admin.03/08/20242,261,465
Brumm Joshua TCEO & President03/11/2024277,000
Brumm Joshua TCEO & President03/08/20242,012,920
Brumm Joshua TCEO & President03/11/20241,704,142
Brumm Joshua TCEO & President03/08/20249,421,634
Beskrovnaya OxanaChief Scientific Officer03/11/202453,482
Brumm Joshua TCEO & President03/07/2024234,873
Beskrovnaya OxanaChief Scientific Officer03/07/202461,342
HIGH SUSANNA GATTIChief Operating Officer03/07/202441,127
Farwell WildonChief Medical Officer03/07/2024256,585
McNeill JonathanChief Business Officer03/07/202462,919
Scalzo Richard WilliamSVP, Head of Finance & Admin.03/07/202458,757
Rhodes Jason PDirector03/01/20241,398,347
Atlas Venture Opportunity Fund I, L.P.10% Owner03/01/2024513,825
Atlas Venture Opportunity Fund I, L.P.10% Owner03/01/2024884,522
Brumm Joshua TCEO & President03/01/2024523,419
Brumm Joshua TCEO & President02/29/202430,581
Brumm Joshua TCEO & President02/29/2024151,800
Brumm Joshua TCEO & President03/01/20242,743,718
McNeill JonathanChief Business Officer03/01/202417,710
McNeill JonathanChief Business Officer02/29/20243,116
McNeill JonathanChief Business Officer03/01/2024694,495
McNeill JonathanChief Business Officer02/29/2024117,370
Scalzo Richard WilliamSVP, Head of Finance & Admin.02/29/20243,532
Scalzo Richard WilliamSVP, Head of Finance & Admin.03/01/20249,590
Scalzo Richard WilliamSVP, Head of Finance & Admin.03/01/2024262,999
Scalzo Richard WilliamSVP, Head of Finance & Admin.02/29/202494,298
Rhodes Jason PDirector02/26/20245,886,673
Rhodes Jason PDirector02/28/20244,741,804
Rhodes Jason PDirector02/27/20248,998,426
Atlas Venture Fund XI, L.P.10% Owner02/28/2024900,228
Atlas Venture Fund XI, L.P.10% Owner02/28/20243,841,576
Atlas Venture Fund XI, L.P.10% Owner02/27/20241,708,338
Atlas Venture Fund XI, L.P.10% Owner02/27/20247,290,088
Atlas Venture Fund XI, L.P.10% Owner02/26/20241,117,577
Atlas Venture Fund XI, L.P.10% Owner02/26/20244,769,096
Farwell WildonChief Medical Officer02/28/202410,175
Rhodes Jason PDirector02/23/20244,470,266
Rhodes Jason PDirector02/22/20242,704,698
Rhodes Jason PDirector02/21/20244,164,817
Atlas Venture Fund XI, L.P.10% Owner02/23/2024848,662
Atlas Venture Fund XI, L.P.10% Owner02/23/20243,621,604
Atlas Venture Fund XI, L.P.10% Owner02/22/20242,704,698
Atlas Venture Fund XI, L.P.10% Owner02/21/20244,164,817
Rhodes Jason PDirector02/20/20243,852,652
Rhodes Jason PDirector02/16/20243,765,040
Rhodes Jason PDirector02/15/20244,249,600
Atlas Venture Fund XI, L.P.10% Owner02/20/20243,852,652
Atlas Venture Fund XI, L.P.10% Owner02/16/20243,765,040
Atlas Venture Fund XI, L.P.10% Owner02/15/20244,249,600
Farwell WildonChief Medical Officer02/12/2024137,710
Farwell WildonChief Medical Officer01/26/20242,500
McNeill JonathanChief Business Officer01/26/202414,600
McNeill JonathanChief Business Officer01/26/2024490,510
Scalzo Richard WilliamSVP, Head of Finance & Admin.01/26/202413,390
Scalzo Richard WilliamSVP, Head of Finance & Admin.01/26/2024316,420
Kersten DirkDirector01/09/202429,999,988
Brumm Joshua TCEO & President01/04/20241,127,092
Brumm Joshua TCEO & President01/03/202452,718
Brumm Joshua TCEO & President01/04/20244,045,958
Brumm Joshua TCEO & President01/03/2024986,957
Beskrovnaya OxanaChief Scientific Officer01/03/202446,686
Beskrovnaya OxanaChief Scientific Officer01/04/202423,354
Beskrovnaya OxanaChief Scientific Officer01/03/2024860,313
Beskrovnaya OxanaChief Scientific Officer01/04/2024769,673
McNeill JonathanChief Business Officer01/04/20241,467
McNeill JonathanChief Business Officer01/03/202413,133
McNeill JonathanChief Business Officer01/04/202436,242
McNeill JonathanChief Business Officer01/03/2024337,062
McNeill JonathanChief Business Officer01/02/2024155,890
Scalzo Richard WilliamSVP, Head of Finance & Admin.01/03/202413,390
Scalzo Richard WilliamSVP, Head of Finance & Admin.01/03/2024244,530
Scalzo Richard WilliamSee Remarks12/14/202328,560
Scalzo Richard WilliamSee Remarks12/11/202314,794
McNeill JonathanChief Business Officer12/11/202313,346
HIGH SUSANNA GATTIChief Operating Officer12/11/202317,324
Farwell WildonChief Medical Officer12/12/202310,318
Farwell WildonChief Medical Officer12/11/202318,095
Brumm Joshua TSee Remarks12/11/202381,311
Beskrovnaya OxanaChief Scientific Officer12/11/202315,726
Scalzo Richard WilliamSee Remarks12/06/202322,483
Scalzo Richard WilliamSee Remarks12/04/20238,179
HIGH SUSANNA GATTIChief Operating Officer11/02/202373,549
Scalzo Richard WilliamSee Remarks09/18/202312,139
McNeill JonathanChief Business Officer09/18/202311,866
HIGH SUSANNA GATTIChief Operating Officer09/18/202325,144
Brumm Joshua TSee Remarks09/18/2023113,221
Beskrovnaya OxanaChief Scientific Officer09/18/202313,513
Farwell WildonChief Medical Officer09/12/202317,770
Scalzo Richard WilliamSee Remarks09/12/202314,543
McNeill JonathanChief Business Officer09/12/202313,179
HIGH SUSANNA GATTIChief Operating Officer09/12/202317,020
Brumm Joshua TSee Remarks09/12/202379,866
Beskrovnaya OxanaChief Scientific Officer09/12/202315,448
Scalzo Richard WilliamSee Remarks06/13/202341,200
Scalzo Richard WilliamSee Remarks06/13/2023532,878
Scalzo Richard WilliamSee Remarks06/15/2023120,300
McNeill JonathanSee Remarks06/13/202315,649
McNeill JonathanSee Remarks06/12/202313,000
HIGH SUSANNA GATTIChief Operating Officer06/13/202320,199
Farwell WildonChief Medical Officer06/13/202321,106
Beskrovnaya OxanaChief Scientific Officer06/13/202318,334
Brumm Joshua TSee Remarks06/08/202330,991
Brumm Joshua TSee Remarks06/12/2023176,501
Brumm Joshua TSee Remarks06/09/202378,879
Brumm Joshua TSee Remarks06/12/20232,367,502
Brumm Joshua TSee Remarks06/09/20231,021,604
Brumm Joshua TSee Remarks06/08/2023806,690
Scalzo Richard WilliamSee Remarks03/14/202317,476
McNeill JonathanSee Remarks03/14/202316,116
McNeill JonathanSee Remarks03/13/202313,000
HIGH SUSANNA GATTIChief Operating Officer03/14/202320,781
Farwell WildonChief Medical Officer03/14/202399,189
Brumm Joshua TSee Remarks03/14/202397,549
Beskrovnaya OxanaChief Scientific Officer03/14/202318,875
McNeill JonathanSee Remarks01/18/20237,300
McNeill JonathanSee Remarks01/18/2023140,300
McNeill JonathanSee Remarks01/09/2023348,835
Rhodes Jason PDirector12/12/202210,000,017
Atlas Venture Opportunity Fund II, L.P.10% Owner12/12/202210,000,017
Scalzo Richard WilliamSee Remarks12/12/20223,391
McNeill JonathanSee Remarks12/12/20225,131
HIGH SUSANNA GATTIChief Operating Officer12/12/20228,163
Farwell WildonChief Medical Officer12/12/20226,826
Brumm Joshua TSee Remarks12/12/202236,110
Beskrovnaya OxanaChief Scientific Officer12/12/20227,392
Brumm Joshua TSee Remarks10/10/2022201,674
Brumm Joshua TSee Remarks10/07/202214,626
Brumm Joshua TSee Remarks10/10/20222,439,668
Brumm Joshua TSee Remarks10/07/2022189,854
Scalzo Richard WilliamSee Remarks09/20/202211,508
McNeill JonathanSee Remarks09/20/202217,070
HIGH SUSANNA GATTIChief Operating Officer09/20/202236,017
Brumm Joshua TSee Remarks09/20/2022162,153
Beskrovnaya OxanaChief Scientific Officer09/20/202219,358
Scalzo Richard WilliamSee Remarks09/15/20224,580
Farwell WildonChief Medical Officer09/15/20229,245
McNeill JonathanSee Remarks09/15/20226,941
HIGH SUSANNA GATTIChief Operating Officer09/15/202211,043
Brumm Joshua TSee Remarks09/15/202248,894
Beskrovnaya OxanaChief Scientific Officer09/15/202210,004
Brumm Joshua TSee Remarks07/06/202290,335
Scalzo Richard WilliamSee Remarks06/14/20221,648
McNeill JonathanSee Remarks06/14/20222,495
HIGH SUSANNA GATTIChief Operating Officer06/14/20223,970
Farwell WildonChief Medical Officer06/14/20223,307
Brumm Joshua TSee Remarks06/14/202217,523
Beskrovnaya OxanaChief Scientific Officer06/14/20223,594
Scalzo Richard WilliamSee Remarks03/11/20222,689
McNeill JonathanSee Remarks03/11/20224,199
HIGH SUSANNA GATTIChief Operating Officer03/11/20226,678
Farwell WildonChief Medical Officer03/11/20225,587
Brumm Joshua TSee Remarks03/11/202229,542
Beskrovnaya OxanaChief Scientific Officer03/11/20226,050
Farwell WildonChief Medical Officer03/02/202248,082
HIGH SUSANNA GATTIChief Operating Officer09/23/202142,206
Scalzo Richard WilliamSee Remarks09/21/20217,926
Scalzo Richard WilliamSee Remarks09/20/20215,729
McNeill JonathanSee Remarks09/21/202111,744
McNeill JonathanSee Remarks09/20/20218,507
Brumm Joshua TSee Remarks09/21/202173,848
Brumm Joshua TSee Remarks09/20/202153,464
Beskrovnaya OxanaChief Scientific Officer09/21/202113,323
Beskrovnaya OxanaChief Scientific Officer09/20/20219,631
VV Manager II, LLC10% Owner09/21/202015,066,905
VV Manager II, LLC10% Owner09/21/2020418,095
Logos Global Management LP10% Owner09/21/202013,300,000
RA CAPITAL MANAGEMENT, L.P.10% Owner09/21/202012,540,000
Load More Insider Transactions
FUNDS WITH A POSITION IN DYNE THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,788,6820.00128%14.57%Other
VIVO CAPITAL, LLC1,035,1361.13%No changeOther
GEODE CAPITAL MANAGEMENT, LLC932,8380.0013%8.76%Other
CANDRIAM S.C.A.763,6240.07%5.53%Other
UBS OCONNOR LLC57,3300.05%-48.24%Value
CHANGE IN SHARES OUTSTANDING FOR DYNE THERAPEUTICS INC
STOCK BUYBACKS FOR DYNE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.49%
1Q
12/31/2023
06/30/2023
2.64%
2Q
12/31/2023
03/31/2023
9.03%
3Q
12/31/2023
12/31/2022
16.25%
4Q
12/31/2023
09/30/2022
18.57%
5Q
12/31/2023
06/30/2022
18.83%
6Q
12/31/2023
03/31/2022
19.01%
7Q
12/31/2023
12/31/2021
19.13%
8Q
12/31/2023
09/30/2021
19.66%
9Q
12/31/2023
06/30/2021
19.91%
10Q
12/31/2023
03/31/2021
24.13%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.49%
1Q
06/30/2023
2.64%
2Q
03/31/2023
9.03%
3Q
12/31/2022
16.25%
4Q
09/30/2022
18.57%
5Q
06/30/2022
18.83%
6Q
03/31/2022
19.01%
7Q
12/31/2021
19.13%
8Q
09/30/2021
19.66%
9Q
06/30/2021
19.91%
10Q
03/31/2021
24.13%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR DYNE THERAPEUTICS INC
LOADING...